Link Cell Therapies

📍 South San Francisco, United States🗓 Founded 2022👥 28 employees💰 Last funded Sep 2025
Biotechnology Research🌐 linkcelltx.com
Website LinkedIn
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Link Cell Therapies?
Link Cell Therapies has 2 investors on record on gritt.io, 2 mid-stage.
When did Link Cell Therapies last raise funding?
The most recent investment in Link Cell Therapies recorded on gritt.io was in September 2025.
When was Link Cell Therapies founded?
Link Cell Therapies was founded in 2022.
What industry is Link Cell Therapies in?
Link Cell Therapies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Link Cell Therapies based?
Link Cell Therapies is headquartered in South San Francisco, United States.